Award
National Cancer Institute 1R01CA316649-01
A novel function of prolactin signaling in brain metastasis in HER2-positive breast cancer
Recipient
Columbia University Health Sciences
Award Amount
$448,017.00
Ceiling
$448,017.00
Awarded
July 17, 2026
Identifier
1R01CA316649-01
Research grant investigating prolactin signaling in brain metastasis of HER2-positive breast cancer to identify new therapeutic targets.
Description
This grant supports research into the mechanisms of brain metastasis in HER2-positive breast cancer, focusing on prolactin signaling pathways and systemic neuroendocrine regulation. It aims to identify therapeutic targets and strategies to prevent or treat metastatic progression.